26.45 USD
▼-0.48-1.08%
盘后 26.74 +0.04%
2026-08-03
市值
$1.76B
市盈率
3.12
EPS
8.55
股息率
—
52 周区间
26.41 – 37.78
成交量
331.48K
Beta
0.12
目标价
25.51
52W 低 26.4152W 高 37.78
价格走势
公司简介
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relaps...